Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy
C.E. Cesta(Karolinska Institutet), Sonia Hernández–Dı́az(Harvard University), Krista F. Huybrechts(Brigham and Women's Hospital), Elisabetta Patorno(Brigham and Women's Hospital), Mika Gissler(Finnish Institute for Health and Welfare), Kari Furu(Norwegian Institute of Public Health), Laura Pazzagli(Karolinska Institutet), EW Seely(Karolinska Institutet), Maarit K. Leinonen(University of Helsinki), B.T. Bateman(Karolinska Institutet), Helga Zoëga(University of Iceland), Ran S. Rotem(Harvard University), Cordula Gabriel(Karolinska Institutet), Jacob Moysés Cohen(Karolinska Institutet), Lars J. Kjerpeseth(Norwegian Institute of Public Health)
Cited by 2
Related Papers
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
|Molecular Cell|2012|3.7k
Association of Genetic and Environmental Factors With Autism in a 5-Country Cohort
|JAMA Psychiatry|2019|622
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
|New England Journal of Medicine|2007|497
The Birth Weight "Paradox" Uncovered?
|American Journal of Epidemiology|2006|359